Validation of potential classification criteria for systemic sclerosis
- PMID: 22052658
- PMCID: PMC3376721
- DOI: 10.1002/acr.20684
Validation of potential classification criteria for systemic sclerosis
Abstract
Objective: Classification criteria for systemic sclerosis (SSc; scleroderma) are being updated jointly by the American College of Rheumatology and European League Against Rheumatism. Potential items for classification were reduced to 23 using Delphi and nominal group techniques. We evaluated the face, discriminant, and construct validity of the items to be further studied as potential criteria.
Methods: Face validity was evaluated using the frequency of items in patients sampled from the Canadian Scleroderma Research Group, 1000 Faces of Lupus, and the Pittsburgh, Toronto, Madrid, and Berlin connective tissue disease (CTD) databases. Patients with SSc (n = 783) were compared to 1,071 patients with diseases similar to SSc (mimickers): systemic lupus erythematosus (n = 499), myositis (n = 171), Sjögren's syndrome (n = 95), Raynaud's phenomenon (RP; n = 228), mixed CTD (n = 29), and idiopathic pulmonary arterial hypertension (PAH; n = 49). Discriminant validity was evaluated using odds ratios (ORs). For construct validity, empirical ranking was compared to expert ranking.
Results: Compared to mimickers, patients with SSc were more likely to have skin thickening (OR 427); telangiectasias (OR 91); anti-RNA polymerase III antibody (OR 75); puffy fingers (OR 35); finger flexion contractures (OR 29); tendon/bursal friction rubs (OR 27); anti-topoisomerase I antibody (OR 25); RP (OR 24); fingertip ulcers/pitting scars (OR 19); anticentromere antibody (OR 14); abnormal nailfold capillaries (OR 10); gastroesophageal reflux disease symptoms (OR 8); antinuclear antibody, calcinosis, dysphagia, and esophageal dilation (all OR 6); interstitial lung disease/pulmonary fibrosis (OR 5); and anti-PM-Scl antibody (OR 2). Reduced carbon monoxide diffusing capacity, PAH, and reduced forced vital capacity had ORs of <2. Renal crisis and digital pulp loss/acroosteolysis did not occur in SSc mimickers (OR not estimated). Empirical and expert ranking were correlated (Spearman's ρ = 0.53, P = 0.01).
Conclusion: The candidate items have good face, discriminant, and construct validity. Further item reduction will be evaluated in prospective SSc and mimicker cases.
Copyright © 2012 by the American College of Rheumatology.
Conflict of interest statement
Sindhu R. Johnson has no financial or other conflicts of interest in relation to this manuscript.
Jaap Fransen has no financial or other conflicts of interest in relation to this manuscript.
Dinesh Khanna has no financial or other conflicts of interest in relation to this manuscript.
Murray Baron has no financial or other conflicts of interest in relation to this manuscript.
Frank van den Hoogen has no financial or other conflicts of interest in relation to this manuscript.
Thomas A. Medsger Jr. has no financial or other conflicts of interest in relation to this manuscript.
Christine A. Peschken has no financial or other conflicts of interest in relation to this manuscript.
Patricia E. Carreira has no financial or other conflicts of interest in relation to this manuscript.
Gabriela Riemekasten has no financial or other conflicts of interest in relation to this manuscript.
Alan Tyndall has no financial or other conflicts of interest in relation to this manuscript.
Marco Matucci-Cerinic has no financial or other conflicts of interest in relation to this manuscript.
Janet E. Pope has no financial or other conflicts of interest in relation to this manuscript.
Figures
Similar articles
-
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424. Ann Rheum Dis. 2013. PMID: 24092682
-
Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.Ann Rheum Dis. 2014 Dec;73(12):2087-93. doi: 10.1136/annrheumdis-2013-203716. Epub 2013 Aug 12. Ann Rheum Dis. 2014. PMID: 23940211
-
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.Arthritis Res Ther. 2011 Jul 22;13(4):R119. doi: 10.1186/ar3422. Arthritis Res Ther. 2011. PMID: 21781293 Free PMC article.
-
Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.Arthritis Res Ther. 2010;12(2):R47. doi: 10.1186/ar2958. Epub 2010 Mar 13. Arthritis Res Ther. 2010. PMID: 20302639 Free PMC article.
-
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3. Arthritis Rheum. 2013. PMID: 24122180 Free PMC article.
Cited by
-
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria.Medicina (Kaunas). 2023 Apr 19;59(4):794. doi: 10.3390/medicina59040794. Medicina (Kaunas). 2023. PMID: 37109752 Free PMC article.
-
Quality Measures in Systemic Sclerosis.Diagnostics (Basel). 2023 Feb 4;13(4):579. doi: 10.3390/diagnostics13040579. Diagnostics (Basel). 2023. PMID: 36832067 Free PMC article. Review.
-
Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application.J Transl Autoimmun. 2022 Jan 4;5:100141. doi: 10.1016/j.jtauto.2022.100141. eCollection 2022. J Transl Autoimmun. 2022. PMID: 35028553 Free PMC article.
-
Systemic sclerosis: To subset or not to subset, that is the question.Eur J Rheumatol. 2020 Oct;7(Suppl 3):S222-S227. doi: 10.5152/eurjrheum.2020.19116. Epub 2020 Jul 6. Eur J Rheumatol. 2020. PMID: 33164736 Free PMC article. Review.
-
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.RMD Open. 2020 Sep;6(2):e001357. doi: 10.1136/rmdopen-2020-001357. RMD Open. 2020. PMID: 32892170 Free PMC article.
References
-
- Masi AT, Medsger TA, Jr, Rodnan GP, Fries JF, Altman RD, Brown BW, et al. Methods and Preliminary Results of the Scleroderma Criteria Cooperative Study of the American Rheumatology Association. ClinRheumDis. 1979;5(1):27–48.
-
- Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581–590. - PubMed
-
- Preliminary criteria for the classification of systemic sclerosis (scleroderma) BullRheumDis. 1981;31(1):1–6. - PubMed
-
- Nadashkevich O, Davis P, Fritzler MJ. A proposal of criteria for the classification of systemic sclerosis. MedSciMonit. 2004;10(11):CR615–CR621. - PubMed
-
- Walker JG, Pope J, Baron M, Leclercq S, Hudson M, Taillefer S, et al. The development of systemic sclerosis classification criteria. Clin Rheumatol. 2007 Sep;26(9):1401–1409. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
